Microba Life Sciences Says Test Demonstrated to Identify Clinically Significant Pathogens

MT Newswires Live

May 21, 2025

Microba Life Sciences (ASX:MAP) said new data showed the ability of its MetaPanel test to identify clinically significant pathogens missed by standard diagnostic approaches, according to a Wednesday Australian bourse filing.

The test is a gastrointestinal pathogen detection panel that screens for 115 pathogens and virulence factors, including bacteria, viruses, and parasites.

Analysis of 889 MetaPanel tests from a patient cohort characterized by long-term gastrointestinal symptoms showed 20% of patients tested positive for a pathogen that can cause gastrointestinal infection. Meanwhile, 58.3% of tests reveal abnormal microbiome results, supporting referral to a MetaXplore test for further investigation.

Around 78.4% of the pathogens detected by the MetaPanel test are often missed by routine pathology tests, per the filing.

Its shares fell 3% on market close Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2537960803"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537960803\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2537960803?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-21 14:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537960803","market":"sh","top_or_hot":-1,"title":"Microba Life Sciences Says Test Demonstrated to Identify Clinically Significant Pathogens","media":"MT Newswires Live","content":"<html><body><p> Microba Life Sciences (ASX:MAP) said new data showed the ability of its MetaPanel test to identify clinically significant pathogens missed by standard diagnostic approaches, according to a Wednesday Australian bourse filing.</p><p>The test is a gastrointestinal pathogen detection panel that screens for 115 pathogens and virulence factors, including bacteria, viruses, and parasites.</p><p>Analysis of 889 MetaPanel tests from a patient cohort characterized by long-term gastrointestinal symptoms showed 20% of patients tested positive for a pathogen that can cause gastrointestinal infection. Meanwhile, 58.3% of tests reveal abnormal microbiome results, supporting referral to a MetaXplore test for further investigation.</p><p>Around 78.4% of the pathogens detected by the MetaPanel test are often missed by routine pathology tests, per the filing.</p><p>Its shares fell 3% on market close Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microba Life Sciences Says Test Demonstrated to Identify Clinically Significant Pathogens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroba Life Sciences Says Test Demonstrated to Identify Clinically Significant Pathogens\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-21 14:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Microba Life Sciences (ASX:MAP) said new data showed the ability of its MetaPanel test to identify clinically significant pathogens missed by standard diagnostic approaches, according to a Wednesday Australian bourse filing.</p><p>The test is a gastrointestinal pathogen detection panel that screens for 115 pathogens and virulence factors, including bacteria, viruses, and parasites.</p><p>Analysis of 889 MetaPanel tests from a patient cohort characterized by long-term gastrointestinal symptoms showed 20% of patients tested positive for a pathogen that can cause gastrointestinal infection. Meanwhile, 58.3% of tests reveal abnormal microbiome results, supporting referral to a MetaXplore test for further investigation.</p><p>Around 78.4% of the pathogens detected by the MetaPanel test are often missed by routine pathology tests, per the filing.</p><p>Its shares fell 3% on market close Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7124","symbol_name":"保健护理服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2537960803","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537960803","pubTimestamp":1747808392,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Microba Life Sciences (ASX:MAP) said new data showed the ability of its MetaPanel test to identify clinically significant pathogens missed by standard diagnostic approaches, according to a Wednesday A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7124":"保健护理服务","MAP.AU":"MICROBA LIFE SCIENCES LTD"},"translate_title":"Microba Life Sciences表示，测试证明可以识别具有临床意义的病原体","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MAP.AU":0.9},"content_text":"Microba Life Sciences (ASX:MAP) said new data showed the ability of its MetaPanel test to identify clinically significant pathogens missed by standard diagnostic approaches, according to a Wednesday Australian bourse filing.The test is a gastrointestinal pathogen detection panel that screens for 115 pathogens and virulence factors, including bacteria, viruses, and parasites.Analysis of 889 MetaPanel tests from a patient cohort characterized by long-term gastrointestinal symptoms showed 20% of patients tested positive for a pathogen that can cause gastrointestinal infection. Meanwhile, 58.3% of tests reveal abnormal microbiome results, supporting referral to a MetaXplore test for further investigation.Around 78.4% of the pathogens detected by the MetaPanel test are often missed by routine pathology tests, per the filing.Its shares fell 3% on market close Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}